Biotechnology
Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know
Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.
Biogen Jumps on Alzheimer's Drug News, But What Do the Charts Say?
Let's take a close look at BIIB and arrive at a strategy for the shares.
Novavax and Its $1.6 Billion Award Just Got My Attention
The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.
Pandora's Scary Box, Apple Optimism?, Regeneron, Trading Sanofi
Markets are clearly different now. I did not grow up, nor was I trained for this environment. Nobody else you hear today was either.
Novavax Could Surprise on the Upside - No Bearish Divergences Yet
Let's review the charts and indicators.
Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine
The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.
Pfizer's Pullback Sweetens the Pill
The drugmaker is a buying opportunity right now.
Alnylam Pharma Poised to Shoot Higher
The biopharmaceutical company shows bullish charts that signal a breakout to new all-time highs. The charts and indicators are bullish,
No Predictions, But 2 Picks for the Second Half of 2020
BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.
Regeneron Pharmaceuticals Has Made a Major Upside Breakout
Now that REGN has clearly broken out above the highs of 2015 there is no chart resistance.